Back to search
FDAFDA · Food and drugs·Recall number D-0520-2020

Amiodarone Hydrochloride Injection, USP, 150 mg per 3 mL (50 mg / mL), 3 mL Single Dose Vial, Rx only, Distributed by AuroMedics Pharma LLC E. Windsor, NJ. 08520, Made in India. NDC 55150-180-03

Published December 4, 2019 · Recall initiated: November 11, 2019

Summary

FDA records drug Class III recall D-0520-2020, published December 4, 2019 and initiated November 11, 2019. Recalling firm: AuroMedics Pharma LLC; Status: Terminated; Reported quantity: 28,810 vials; Lot: Lot# CAH180009, exp. date Feb 2020. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Crystallization: Presence of visible particulate matter.

What to do

Voluntary: Firm initiated · Letter

Get an email if AMIODARONE HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
AMIODARONE HYDROCHLORIDE
Manufacturer
AuroMedics Pharma LLC
Distributor
Distributed Nationwide in the US
UPC
0355150180035
Lot
Lot# CAH180009, exp. date Feb 2020
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Amiodarone Hydrochloride Injection, USP, 150 mg per 3 mL (50 mg / mL), 3 mL Single Dose Vial, Rx only, Distributed by AuroMedics Pharma LLC E. Windsor, NJ. 08520, Made in India. NDC 55150-180-03 recalled?

Yes. FDA published recall D-0520-2020 on December 4, 2019. Reported hazard: Crystallization: Presence of visible particulate matter.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: AMIODARONE HYDROCHLORIDE. UPC: 0355150180035.